STOCK TITAN

Amprius (NYSE: AMPX) to swap 7.1M public warrants for stock

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Amprius Technologies, Inc. entered into Warrant Exchange Agreements with certain institutional holders of its public warrants. These holders agreed to exchange an aggregate of 7,128,458 public warrants, each with a strike price of $11.50 per share, for shares of common stock.

The number of shares each holder receives will be based on a formula using the four-day average volume-weighted average price of the common stock, adjusted by adding $0.35 and subtracting the exercise price, then dividing by the same average price. Closing of the exchanges is expected on May 18, 2026, subject to customary conditions, and the unregistered issuance of these shares relies on the Section 4(a)(2) exemption under the Securities Act.

Positive

  • None.

Negative

  • None.

Insights

Amprius is replacing public warrants with common shares via a formula-based exchange.

Amprius Technologies agreed with institutional holders to exchange 7,128,458 public warrants, each exercisable at $11.50 per share, for common stock. The share amount per warrant depends on a formula tied to the four-day average volume-weighted average price of the stock, plus $0.35 and minus the exercise price.

The transaction is expected to close on May 18, 2026, subject to customary conditions, and is structured as an unregistered issuance relying on Section 4(a)(2) of the Securities Act. Actual effects on ownership and trading will depend on the calculated exchange ratio and how the new shares interact with existing market dynamics.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Public warrants exchanged 7,128,458 warrants Aggregate Exchange Public Warrants subject to Warrant Exchange Agreements
Warrant exercise price $11.50 per share Exercise price of each existing Exchange Public Warrant
VWAP adjustment amount $0.35 Added to the Average VWAP before subtracting the exercise price in the exchange formula
Expected closing date May 18, 2026 Anticipated closing of exchanges, subject to customary conditions
Warrant Exchange Agreements financial
"entered into Warrant Exchange Agreements (the “Exchange Agreements”) with certain institutional holders"
volume-weighted average price financial
"the average volume-weighted average price of the Common Stock over a four day consecutive trading period"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
Section 4(a)(2) of the Securities Act regulatory
"being made in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended"
A legal exemption that allows a company to sell securities directly to a limited group of buyers without registering the offering with the Securities and Exchange Commission. Think of it like a private sale among known parties rather than a public auction: it can speed fundraising and reduce disclosure requirements, but it also means less public information, lower liquidity and resale restrictions—factors investors should consider when weighing risk and exit options.
Unregistered Sales of Equity Securities regulatory
"Item 3.02 Unregistered Sales of Equity Securities"
0001899287FALSEfalse000189928700018992872026-05-062026-05-060001899287us-gaap:CommonStockMember2026-05-062026-05-060001899287ampx:RedeemableWarrantsMember2026-05-062026-05-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________
FORM 8-K
_________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 6, 2026
_________________________
Amprius Technologies, Inc.
(Exact name of Registrant as Specified in Its Charter)
_________________________
Delaware001-4131498-1591811
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
1180 Page Ave
Fremont, California
94538
(Address of Principal Executive Offices)(Zip Code)
Registrant’s Telephone Number, Including Area Code: (800) 425-8803
N/A
(Former Name or Former Address, if Changed Since Last Report)
_________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)
Name of each exchange
on which registered
Common stock, par value $0.0001 per shareAMPXThe New York Stock Exchange
Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50AMPX.WThe New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 1.01 Entry into Material Definitive Agreement

On May 6, 2026, Amprius Technologies, Inc. (the “Company”) entered into Warrant Exchange Agreements (the “Exchange Agreements”) with certain institutional holders (the “Public Warrant Holders”) of the Company’s public warrants (the “Exchange Public Warrants”), each of which is exercisable to purchase one share of common stock of the Company, par value $0.0001 per share (“Common Stock”), at an exercise price of $11.50 (the “Exercise Price”) per existing Exchange Public Warrant. Pursuant to the Exchange Agreements, the Public Warrant Holders agreed to exchange an aggregate of 7,128,458 Exchange Public Warrants for shares of Common Stock (the “Exchange Shares”).

Pursuant to the terms of the Exchange Agreements, Public Warrant Holders will receive, for the Exchange Public Warrants exchanged, a number of Exchange Shares equal to the product of (i) the number of Exchange Public Warrants so surrendered multiplied by (ii) the quotient of (a) the sum of (x) the average volume-weighted average price of the Common Stock over a four day consecutive trading period (the “Average VWAP”), (y) plus $0.35, (z) minus the Exercise Price, divided by (b) the Average VWAP.

The closing of the exchanges of the Exchange Public Warrants for Exchange Shares is expected to occur on May 18, 2026, and is subject to customary closing conditions.

The Exchange Agreements contain customary representations, warranties, covenants, and other obligations of the parties. The representations, warranties and covenants contained in the Exchange Agreements were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties.

The above summary of the Exchange Agreements does not purport to be complete and is qualified in its entirety to the full text of the form of Exchange Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K.

Item 3.02 Unregistered Sales of Equity Securities

The disclosures set forth above under Item 1.01 are incorporated herein by reference. The issuance by the Company of the Exchange Shares in exchange for the surrender and cancellation of the Exchange Public Warrants is being made in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), in reliance in part on the representations, warranties and covenants made by the Public Warrant Holders. The Exchange Shares to be issued pursuant to the Exchange Agreements may not be re-offered or sold in the United States absent an effective registration statement or an exemption from the registration requirements under applicable federal and state securities laws.

Item 9.01    Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Description
10.1
Form of Warrant Exchange Agreement
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMPRIUS TECHNOLOGIES, INC.
Date: May 7, 2026By:/s/ Ricardo C. Rodriguez
Name: Ricardo C. Rodriguez
Title: Chief Financial Officer

FAQ

What did Amprius Technologies (AMPX) announce regarding its public warrants?

Amprius Technologies entered into Warrant Exchange Agreements with institutional holders to swap 7,128,458 public warrants for common stock. Each warrant is currently exercisable at $11.50 per share, and the exchange is intended to replace those warrants with shares using a defined pricing formula.

How many Amprius (AMPX) public warrants are subject to the exchange?

An aggregate of 7,128,458 public warrants are covered by the exchange. These are existing warrants, each exercisable for one share of common stock at an $11.50 exercise price, that participating institutional holders agreed to surrender in return for newly issued common shares.

How is the Amprius (AMPX) warrant-for-share exchange ratio calculated?

The number of Amprius shares per warrant equals the number of warrants surrendered multiplied by a quotient. That quotient is the four-day average volume-weighted average price of the stock, plus $0.35, minus the $11.50 exercise price, then divided by the same average price of the common stock.

When is the Amprius (AMPX) warrant exchange expected to close?

The exchanges of Amprius public warrants for common stock are expected to close on May 18, 2026. Completion is subject to customary closing conditions specified in the Warrant Exchange Agreements, which include standard representations, warranties, covenants, and other obligations between the company and participating holders.

Is the Amprius (AMPX) warrant exchange a registered offering of shares?

No, the Amprius exchange shares will be issued in an unregistered transaction relying on Section 4(a)(2) of the Securities Act. The common shares issued may not be re-offered or sold in the United States without an effective registration statement or a valid exemption from registration requirements.

Who are the primary participants in the Amprius (AMPX) Warrant Exchange Agreements?

The agreements are between Amprius Technologies and certain institutional public warrant holders. These holders currently own the public warrants being surrendered and will receive exchange shares of Amprius common stock, subject to the formula and conditions described in the Warrant Exchange Agreements.

Filing Exhibits & Attachments

5 documents